Keyphrases
Italy
100%
Cost-effectiveness
100%
Multiple Sclerosis
100%
Sativex
100%
Multiple Sclerosis Spasticity
100%
Spasticity
66%
Quality-adjusted Life Years
33%
Life-years Gained
33%
Disability
16%
Daily Clinical Practice
16%
Health Systems
16%
Treatment Options
16%
Spanish Context
16%
Tetrahydrocannabinol
16%
Add-on Therapy
16%
Progressive Disease
16%
Probabilistic Sensitivity Analysis
16%
Chronic Progressive
16%
Markov Model
16%
Cost-effective Treatment
16%
Incremental Cost-effectiveness Ratio
16%
Spasm
16%
Model-based Analysis
16%
Healthcare Contexts
16%
Socioeconomic Burden
16%
Oromucosal Spray
16%
Cannabidiol
16%
Pharmacology, Toxicology and Pharmaceutical Science
Multiple Sclerosis
100%
Spasticity
100%
Nabiximols
100%
Add on Therapy
14%
Base
14%
Muscle Spasm
14%
Diseases
14%